Hoth Therapeutics Inc. Stock News

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced the addition of two independent members, Mr. Graig Springer and Mr. Wayne Linsley, to its Board of Directors. The C

The FDA has signed off on Fast Track status for Yantai, China-based RemeGen's lead drug RC18 for the treatment of systemic lupus erythematosus (SLE).RC18 (telitacicept) is a recombinant TACI-F

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Dr. Mark Poznansky, Co-Creator of VaxCelerate, a self-assembling vaccine (SAV) platform, appeared as a guest o

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced initiating the next phase of its study of VNLG-152 novel retinamides (Retinoic acid metabolism blocking agents or R

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced its joint venture entity with Voltron Therapeutics, Inc., HaloVax, has entered into a Sponsored Research Agreement

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has entered into a non-binding letter of intent ("LOI") with Isoprene Pharmaceuticals, Inc. to acquire the full

Astrotech (NASDAQ:ASTC) +59% as breathTest-1000 confirmed to detect lung disease metabolites at parts per billion.MFA Financial (NYSE:MFA) +26%.Hoth Therapeutics (NASDAQ:HOTH) +22% on agreement wi

Humanigen (OTCQB:HGEN) has submitted a protocol synopsis to the FDA related to its planned Phase 3 study of lenzilumab for the prevention and treatment of cytokine storm in COVID-19 patients.Hoth Ther

HaloVax, LLC a biopharmaceutical company and special purpose subsidiary of Voltron Therapeutics, Inc., announced they have reached an agreement with Hoth Therapeutics, Inc (NASDAQ: HOTH) (previously r

The biotech sector is in focus with pipeline updates from companies evaluating treatments for the novel COVID-19.

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) Arcutis Biotherapeutics...

Toward the end of trading Monday, the Dow traded down 3.09% to 18,581. while the NASDAQ fell 0.93% to 6,815. The S&P also fell, dropping 3.09% to 2,234. US reported a total of...

Gainers Hoth Therapeutics, Inc (NASDAQ: HOTH) shares jumped 99% to $5.50 after the company reported a deal to jointly develop self-assembling vaccine for potential coronavirus...

Midway through trading Monday, the Dow traded down 3.97% to 18,411.95 while the NASDAQ fell 2.65% to 6,697.06. The S&P also fell, dropping 3.81% to 2,217.05. US reported a...